Correlation Between Monster Beverage and Tscan Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monster Beverage and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monster Beverage and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monster Beverage Corp and Tscan Therapeutics, you can compare the effects of market volatilities on Monster Beverage and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monster Beverage with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monster Beverage and Tscan Therapeutics.

Diversification Opportunities for Monster Beverage and Tscan Therapeutics

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Monster and Tscan is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Monster Beverage Corp and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Monster Beverage is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monster Beverage Corp are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Monster Beverage i.e., Monster Beverage and Tscan Therapeutics go up and down completely randomly.

Pair Corralation between Monster Beverage and Tscan Therapeutics

Given the investment horizon of 90 days Monster Beverage is expected to generate 1.52 times less return on investment than Tscan Therapeutics. But when comparing it to its historical volatility, Monster Beverage Corp is 2.52 times less risky than Tscan Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  454.00  in Tscan Therapeutics on September 1, 2024 and sell it today you would earn a total of  23.00  from holding Tscan Therapeutics or generate 5.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Monster Beverage Corp  vs.  Tscan Therapeutics

 Performance 
       Timeline  
Monster Beverage Corp 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Monster Beverage Corp are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Monster Beverage unveiled solid returns over the last few months and may actually be approaching a breakup point.
Tscan Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Monster Beverage and Tscan Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monster Beverage and Tscan Therapeutics

The main advantage of trading using opposite Monster Beverage and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monster Beverage position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.
The idea behind Monster Beverage Corp and Tscan Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets